Harrison Dillon

President and Chief Technology Officer, Solazyme Inc.

Studies in Microbial Genetics, Microbiology and Immunology Department, Emory University; PhD in Genetics, Department of Human Genetics, University of Utah; JD, Duke University School of Law; licensed to practice before US Patent and Trademark Office. Formerly: managed biotechnology patent portfolio, Technology Transfer Office, University of Utah; Associate, Biotechnology Group, Townsend and Townsend. With Solazyme: inventor on over 30 of its patents and patent applications and oversees IP portfolio. Member of several advisory boards. Member, State Bar of California. Author of articles in scientific, business and legal journals.

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum